2m 2m 2m 2m 2m 2m 2m
Acadia Pharma (ACAD)
NASDAQ
$20.22+$0.33 (+1.68%)
Price as of Oct 02, 2026 6:27 PM EDT- $3.4BMarket Cap
- -6.97%1-Year Change
- BiotechnologyIndustry
Acadia Pharma (ACAD)
$20.22+$0.33 (+1.68%)
ACAD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $19.89 | ||
Change | -$0.26 (-1.29%) | ||
Open | $19.95 | ||
High | $20.19 | ||
Low | $19.59 | ||
Previous Close | $20.15 | ||
Volume | 2,731,696 | ||
30-Day Average Volume | 2,179,623 | ||
1-Week Change | -10.32% | ||
1-Month Change | -31.15% | ||
1-Year Change | -6.97% | ||
3-Year Change | -4.56% | ||
5-Year Change | 13.79% | ||
Fundamentals | |||
Shares Outstanding | 172.3M | ||
Total Assets | $1.7B | ||
Market Cap | $3.4B | ||
Enterprise Value | $3.0B | ||
Period: QTR TTM FY | |||
Revenue | $308.0M | ||
Net Income | $31.5M | ||
Free Cash Flow | $95.7M | ||
EBIT | $46.5M | ||
EBITDA | $49.2M | ||
Net Working Capital | $863.1M | ||
EPS | $0.18 | ||
Enterprise Value/EBITDA | 62 | ||
Enterprise Value/Revenue | 10 | ||
P/B | 3 | ||
P/E | 111 | ||
PEG | 0 | ||
Price/Free Cash Flow | 36 | ||
Price/Operating Cash Flow | 34 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue